CVE-2023-40153 — The affected product is vulnerable to a cross-site scripting vulnerability, whic

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

01What is this vulnerability?

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

02Affected products

Vendor	Product	Versions
DEXMA	DexGate	20130114

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Open the Sigma generator with a pre-filled prompt for this CVE to draft a starting detection in your stack of choice:

Open in Sigma generator →

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2023-10-19T18:05:42.988Z
• Last modified: 2024-09-11T20:09:53.916Z

09References

• www.cisa.gov — https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02